glucose, (beta-d)-isomer has been researched along with Foot Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ivanovska, N; Kuyumdjieva, A; Neychev, H; Stefanova, Z; Valeva, V | 1 |
| Calapai, G; Caputi, AP; Cuzzocrea, S; Nava, F; Zingarelli, B | 1 |
| Gomez, L; Perez, Y; Simpson, BK; Valdivia, A; Villalonga, R | 1 |
3 other study(ies) available for glucose, (beta-d)-isomer and Foot Diseases
| Article | Year |
|---|---|
Antiinflammatory effect of superoxide dismutase (SOD). Comparison between yeast and bovine SOD on some complement-mediated reactions in vitro and in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cattle; Complement System Proteins; Edema; Enzyme Stability; Foot Diseases; Hemolysis; Immunoglobulin G; Kluyveromyces; Mice; Superoxide Dismutase; Zymosan | 1994 |
Zymosan-activated plasma induces paw oedema by nitric oxide and prostaglandin production.
Topics: Animals; Arginine; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Edema; Enzyme Inhibitors; Foot Diseases; Hemoglobins; Indomethacin; Inflammation; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; omega-N-Methylarginine; Prostaglandins; Rats; Zymosan | 1997 |
Glycosidation of cu,zn-superoxide dismutase with end-group aminated dextran: pharmacological and pharmacokinetics properties.
Topics: Amines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Aspartic Acid; Carbohydrate Sequence; Dextrans; Edema; Enzyme Activation; Foot Diseases; Glucosides; Glutamic Acid; Half-Life; Male; Molecular Sequence Data; Rats; Rats, Wistar; Superoxide Dismutase | 2005 |